EVs Answer to the CAR-Tease: Targeted Exosomes to Speed Toward Next-Gen Immunotherapies October 01, 2024 Exosomes / Extracellular Vesicles, Genetic Engineering
MSCs vs. Cancer — Armed with a Better Sword, the Crab Loses July 17, 2024 Cell Therapy, Exosomes / Extracellular Vesicles, Genetic Engineering, MSCs & Characterization
In a World of SynBio… One Professor Engineers Smart Cells for Tissue Repair May 24, 2024 Bioprinting & Biofabrication, Genetic Engineering, MSCs & Characterization
Boost at the Roost: Unleashing the Power of Cell Engineering for Your MSC & Exosome Therapies April 22, 2024 Cell Therapy, Exosomes / Extracellular Vesicles, Genetic Engineering
The Immortal Question: Can MSCs Be “Like a Cell Line But Not a Cell Line?” March 29, 2024 Exosomes / Extracellular Vesicles, Genetic Engineering, MSCs & Characterization
miRNA, miRNA in the QIAzol®, Where’s the Fingerprint Among Them All? November 16, 2023 Exosomes / Extracellular Vesicles, Genetic Engineering
How to Achieve High mRNA Transfection Efficiencies in Primary Adherent Cells October 31, 2023 Corporate, Genetic Engineering
Logical Scale Out Before Scale Up September 22, 2023 Bioprocessing, Exosomes / Extracellular Vesicles, Genetic Engineering
RoosterBio at ASGCT-2023: Confidently Crowing in a Crowd of CRISPRs, Capsids, & CARs June 19, 2023 Cell Therapy, Conference Highlights, Genetic Engineering
